Inogen Announces Participation in 29th Annual Piper Jaffray Healthcare Conference
November 27 2017 - 4:00PM
Business Wire
Inogen, Inc. (NASDAQ: INGN), a medical technology company
offering innovative respiratory products for use in the homecare
setting, today announced that the Company’s management will be
participating in the 29th Annual Piper Jaffray Healthcare
Conference in New York City.
Inogen’s President and CEO, Scott Wilkinson and CFO, Alison
Bauerlein are scheduled to present on Wednesday, November 29, 2017
at 10:30 a.m. ET. Interested parties can access the live audio
webcast of this event from the Events section of the Investor
Relations page on the Inogen website at www.inogen.com. A webcast
replay will be available approximately one hour after the
conclusion of the live presentation and will remain available for
90 days.
Inogen has used, and intends to continue to use, its Investor
Relations website, http://investor.inogen.com/, as a means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.
About Inogen
Inogen is innovation in oxygen therapy. We are a medical
technology company that develops, manufactures and markets
innovative oxygen concentrators used to deliver supplemental
long-term oxygen therapy to patients suffering from chronic
respiratory conditions.
For more information, please visit www.inogen.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171127005939/en/
Inogen, Inc.Investor Relations Contact:Matt Bacso,
CFA805-879-8205orMedia Contact:Byron Myers805-562-0503
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Apr 2024 to May 2024
Inogen (NASDAQ:INGN)
Historical Stock Chart
From May 2023 to May 2024